58 related articles for article (PubMed ID: 21243030)
1. Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT.
Tormo N; Solano C; Benet I; Nieto J; de la Cámara R; López J; Garcia-Noblejas A; Muñoz-Cobo B; Costa E; Clari MA; Hernández-Boluda JC; Remigia MJ; Navarro D
Bone Marrow Transplant; 2011 Nov; 46(11):1437-43. PubMed ID: 21243030
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen.
Mohty M; Mohty AM; Blaise D; Faucher C; Bilger K; Isnardon D; Sainty D; Gastaut JA; Viens P; Olive D; Gaugler B
Bone Marrow Transplant; 2004 Apr; 33(8):839-46. PubMed ID: 14767500
[TBL] [Abstract][Full Text] [Related]
3. Peptide vaccination in the presence of adjuvants in patients after hematopoietic stem cell transplantation with CD4+ T cell reconstitution elicits consistent CD8+ T cell responses.
Schmitt M; Schmitt A; Wiesneth M; Hückelhoven A; Wu Z; Kuball J; Wang L; Schauwecker P; Hofmann S; Götz M; Michels B; Maccari B; Wuchter P; Eckstein V; Mertens T; Schnitzler P; Döhner H; Ho AD; Bunjes DW; Dreger P; Schrezenmeier H; Greiner J
Theranostics; 2017; 7(6):1705-1718. PubMed ID: 28529646
[No Abstract] [Full Text] [Related]
4. Dynamics of cytomegalovirus-specific T-cell recovery in allogeneic hematopoietic cell transplant recipients using a commercially available flow cytometry assay: A pilot study.
Jacobs SE; Ibrahim U; Vega AB; Lagdameo J; Callahan J; Govindarajulu U; Gitman M; Levine JE; Rana M; Keyzner A
Transpl Infect Dis; 2024 May; ():e14290. PubMed ID: 38708941
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus-Specific T Cells in Pediatric Liver Transplant Recipients.
Getsuwan S; Apiwattanakul N; Lertudomphonwanit C; Hongeng S; Boonsathorn S; Manuyakorn W; Tanpowpong P; Anurathapan U; Tangnararatchakit K; Treepongkaruna S
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005890
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus burden improves a predictive model identifying measures of vascular risk in renal transplant recipients and healthy adults.
Affandi JS; Lee S; Chih H; Brook E; Waters S; Howson P; Reid CM; Irish A; Price P
J Med Virol; 2020 Dec; 92(12):3650-3657. PubMed ID: 32017150
[TBL] [Abstract][Full Text] [Related]
7. T-Cell Immune Responses in Newborns and Long-Term Sequelae in Congenital Cytomegalovirus Infection (CYTRIC Study).
Soriano-Ramos M; Pedrero-Tomé R; Giménez-Quiles E; Albert E; Baquero-Artigao F; Rodríguez-Molino P; Del Rosal T; Noguera-Julian A; Fortuny C; Ríos-Barnés M; Saavedra-Lozano J; Dueñas E; Sánchez-Mateos M; Castells L; de la Serna M; Frick MA; de Vergas J; Núñez-Enamorado N; Moral-Pumarega MT; Folgueira MD; Navarro D; Blázquez-Gamero D;
J Pediatr; 2024 May; 272():114084. PubMed ID: 38705230
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus-specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis.
La Rosa C; Aldoss I; Park Y; Yang D; Zhou Q; Gendzekhadze K; Kaltcheva T; Rida W; Dempsey S; Arslan S; Artz A; Ball B; Nikolaenko L; Pullarkat VA; Nakamura R; Diamond DJ
Am J Hematol; 2023 Apr; 98(4):588-597. PubMed ID: 36594185
[TBL] [Abstract][Full Text] [Related]
9. Patient risk stratification and tailored clinical management of post-transplant CMV-, EBV-, and BKV-infections by monitoring virus-specific T-cell immunity.
Papadopoulou A; Koukoulias K; Alvanou M; Papadopoulos VK; Bousiou Z; Kalaitzidou V; Kika FS; Papalexandri A; Mallouri D; Batsis I; Sakellari I; Anagnostopoulos A; Yannaki E
EJHaem; 2021 Aug; 2(3):428-439. PubMed ID: 35844677
[TBL] [Abstract][Full Text] [Related]
10. A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol.
García-García I; Guerra-García P; Ferreras C; Borobia AM; Carcas AJ; Queiruga-Parada J; Vicario JL; Mirones I; Solano C; Eguizabal C; Soria B; Pérez-Martínez A
Trials; 2021 Oct; 22(1):674. PubMed ID: 34600562
[TBL] [Abstract][Full Text] [Related]
11. Viral Infections in HSCT: Detection, Monitoring, Clinical Management, and Immunologic Implications.
Annaloro C; Serpenti F; Saporiti G; Galassi G; Cavallaro F; Grifoni F; Goldaniga M; Baldini L; Onida F
Front Immunol; 2020; 11():569381. PubMed ID: 33552044
[TBL] [Abstract][Full Text] [Related]
12. The CD4+ T Cell Response to Human Cytomegalovirus in Healthy and Immunocompromised People.
Lim EY; Jackson SE; Wills MR
Front Cell Infect Microbiol; 2020; 10():202. PubMed ID: 32509591
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study.
Chemaly RF; El Haddad L; Winston DJ; Rowley SD; Mulane KM; Chandrasekar P; Avery RK; Hari P; Peggs KS; Kumar D; Nath R; Ljungman P; Mossad SB; Dadwal SS; Blanchard T; Shah DP; Jiang Y; Ariza-Heredia E
Clin Infect Dis; 2020 Dec; 71(9):2365-2374. PubMed ID: 32076709
[TBL] [Abstract][Full Text] [Related]
14. Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial.
Aldoss I; La Rosa C; Baden LR; Longmate J; Ariza-Heredia EJ; Rida WN; Lingaraju CR; Zhou Q; Martinez J; Kaltcheva T; Dagis A; Hardwick N; Issa NC; Farol L; Nademanee A; Al Malki MM; Forman S; Nakamura R; Diamond DJ;
Ann Intern Med; 2020 Mar; 172(5):306-316. PubMed ID: 32040960
[TBL] [Abstract][Full Text] [Related]
15. Viral opportunistic infections in Mauritian cynomolgus macaques undergoing allogeneic stem cell transplantation mirror human transplant infectious disease complications.
Wu HL; Weber WC; Shriver-Munsch C; Swanson T; Northrup M; Price H; Armantrout K; Robertson-LeVay M; Reed JS; Bateman KB; Mahyari E; Thomas A; Junell SL; Hobbs TR; Martin LD; MacAllister R; Bimber BN; Slifka MK; Legasse AW; Moats C; Axthelm MK; Smedley J; Lewis AD; Colgin L; Meyers G; Maziarz RT; Burwitz BJ; Stanton JJ; Sacha JB
Xenotransplantation; 2020 Jul; 27(4):e12578. PubMed ID: 31930750
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Characterization of a Next-Generation Antiviral T-Cell Product and Feasibility for Application in Immunosuppressed Transplant Patients.
Amini L; Vollmer T; Wendering DJ; Jurisch A; Landwehr-Kenzel S; Otto NM; Jürchott K; Volk HD; Reinke P; Schmueck-Henneresse M
Front Immunol; 2019; 10():1148. PubMed ID: 31191530
[TBL] [Abstract][Full Text] [Related]
17. Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Stern L; Withers B; Avdic S; Gottlieb D; Abendroth A; Blyth E; Slobedman B
Front Microbiol; 2019; 10():1186. PubMed ID: 31191499
[TBL] [Abstract][Full Text] [Related]
18. Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVax.
La Rosa C; Longmate J; Lingaraju CR; Zhou Q; Kaltcheva T; Hardwick N; Aldoss I; Nakamura R; Diamond DJ
Biol Blood Marrow Transplant; 2019 Apr; 25(4):771-784. PubMed ID: 30562587
[TBL] [Abstract][Full Text] [Related]
19. The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
Albert E; Solano C; Giménez E; Focosi D; Pérez A; Macera L; Piñana JL; Boluda JCH; Maggi F; Navarro D
Bone Marrow Transplant; 2018 Feb; 53(2):180-187. PubMed ID: 29084205
[TBL] [Abstract][Full Text] [Related]
20. Reconstitution of adaptive immunity after umbilical cord blood transplantation: impact on infectious complications.
Servais S; Hannon M; Peffault de Latour R; Socie G; Beguin Y
Stem Cell Investig; 2017; 4():40. PubMed ID: 28607914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
